Viewing Study NCT00912418


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-03-09 @ 8:37 AM
Study NCT ID: NCT00912418
Status: COMPLETED
Last Update Posted: 2020-03-02
First Post: 2009-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma
Sponsor: Craig L Slingluff, Jr
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None melanoma View
None vaccine View
None IL2 low dose View